Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Marc Ferec"'
Autor:
Karim Amrane, Philippe Thuillier, David Bourhis, Coline Le Meur, Chloe Quere, Jean-Christophe Leclere, Marc Ferec, Veronique Jestin-Le Tallec, Laurent Doucet, Pierre Alemany, Pierre-Yves Salaun, Jean-Philippe Metges, Ulrike Schick, Ronan Abgral
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-11 (2023)
Abstract The main aim of this study was to evaluate the prognostic value of radiomic approach in pre-therapeutic 18F-fluorodeoxyglucose positron-emission tomography (FDG-PET/CT) in a large cohort of patients with gastro-esophageal junction cancer (GE
Externí odkaz:
https://doaj.org/article/9c06887eb2e047218fac155ba9763e1b
Autor:
Karim Amrane, Philippe Thuillier, David Bourhis, Coline Le Meur, Chloe Quere, Jean-Christophe Leclere, Marc Ferec, Veronique Jestin-Le Tallec, Laurent Doucet, Pierre Alemany, Pierre-Yves Salaun, Jean-Philippe Metges, Ulrike Schick, Ronan Abgral
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-1 (2023)
Externí odkaz:
https://doaj.org/article/d2fad35265b444fba3cf77cd4083c3d4
Autor:
Olivier Capitain, Valérie Seegers, Jean-Philippe Metges, Roger Faroux, Claire Stampfli, Marc Ferec, Tamara Matysiak Budnik, Hélène Senellart, Valérie Rossi, Nadège Blouin, Jonathan Dauvé, Mario Campone
Publikováno v:
Dose-Response, Vol 18 (2020)
Background: Fluoropyrimidines (FPs) carry around 20% risk of G3-5 toxicity and 0.2-1% risk of death, due to dihydropyrimidine dehydrogenase (DPD) deficiency. Several screening approaches exist for predicting toxicity, however there is ongoing debate
Externí odkaz:
https://doaj.org/article/9c3b1ee33d43405b93a404a522196262
Autor:
Tamara Matysiak Budnik, Jean-Philippe Metges, Hélène Senellart, Olivier Capitain, Roger Faroux, Marc Ferec, Mario Campone, Jonathan Dauve, Nadege Blouin, Valérie Rossi, Valérie Seegers, Claire Stampfli
Publikováno v:
Dose-Response
Dose-Response, Vol 18 (2020)
Dose-Response, Vol 18 (2020)
Background: Fluoropyrimidines (FPs) carry around 20% risk of G3-5 toxicity and 0.2-1% risk of death, due to dihydropyrimidine dehydrogenase (DPD) deficiency. Several screening approaches exist for predicting toxicity, however there is ongoing debate
Autor:
Sylvain Manfredi, Eric Terrebonne, Gael Deplanque, Jean-Yves Scoazec, Anne-Laure Ran-Royo, Marc Ferec, Guillaume Cadiot, Eric Maringe, C. Desauw, Philippe Rougier, Thomas Aparicio, Castex, Guillaume Geslin, Jean-François Seitz, François Dewaele, Karine Bouhier-Leporrier, Vincent Hautefeuille, Anne Thirot-Bidault, Olivia Hentic, G. Roquin, David Tougeron, Olivier Dubreuil, C. Rebischung, Laetitia Dahan, Ivan Borbath, Jean-Louis Legoux, Laurent Bedenne, Sandrine Lavau denes, Catherine Ligeza, Mathieu Baconnier, K. Le Malicot, Laurent Cany, Côme Lepage, Thierry Lecomte, Céline Lepère, I. Bonnet, Valérie Rossi, Isabelle Wanicki Caron, Laetitia Stephanie, Cedric Lecaille, Eric Baudin, Thomas Walter, David Malka, Patricia Niccoli, Vincent Bourgeois, Etienne Suc, Joël Guigay, Romain Coriat, Rosine Guimbaud, Catherine Lombard-Bohas, Caroline Petorin
Publikováno v:
European Journal of Cancer
European Journal of Cancer, Elsevier, 2017, 79, pp.158-165. ⟨10.1016/j.ejca.2017.04.009⟩
European Journal of Cancer, Elsevier, 2017, 79, pp.158-165. ⟨10.1016/j.ejca.2017.04.009⟩
IF 6.029; International audience; BackgroundDiagnosis and management of poorly differentiated gastro-entero-pancreatic (GEP) neuroendocrine carcinomas (NECs) remain challenging. Recent studies suggest prognostic heterogeneity. We designed within the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::277f17292626831e97736d344d5e6941
https://hal-univ-bourgogne.archives-ouvertes.fr/hal-01609152
https://hal-univ-bourgogne.archives-ouvertes.fr/hal-01609152
Autor:
Jean-Philippe Metges, Tamara Matysiak-Budnik, Roger Faroux, Marc Ferec, Nadege Blouin, Hélène Senellart, Mario Campone, Michèle Boisdron-Celle, Valérie Rossi, Valérie Seegers, Claire Stampfli, Jonathan Dauve, Olivier Capitain
Publikováno v:
Journal of Clinical Oncology. 37:3529-3529
3529 Background: Severe, sometimes fatal, toxicity can occur during the 1st or 2nd course of chemotherapy using fluoropyrimidines (FPs), and poses a serious public health problem. FPs carry a 3-5% risk of grade ≥ 3 early toxicities and 0.2% risk of
Assessing 2-month clinical prognosis in patients with solid tumors: Final results of PRONOPALL study
Autor:
Hugues Pierre Bourgeois, Philippe Solal-Celigny, Olivier Capitain, Emmanuelle Bourbouloux, Julien Baudon, Marie Marcq, Eveline Boucher, Valérie Delecroix, Emmanuel Blot, MARC Ferec, Joelle Egreteau, Xavier Artignan, Stephane Corbinais, Corinne Alleaume, Oana Cojocarasu, Anne-Claire Hardy-Bessard, Emmanuel Naudeix, Virginie Berger, Pierre Ingrand, Francoise Grude
Publikováno v:
Journal of Clinical Oncology. 32:9558-9558